Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63


Adapter-mediated substrate selection for endoplasmic reticulum-associated degradation.

Corcoran K, Wang X, Lybarger L.

J Biol Chem. 2009 Jun 26;284(26):17475-87. doi: 10.1074/jbc.M808258200. Epub 2009 Apr 14.


MHC class II transport at a glance.

Berger AC, Roche PA.

J Cell Sci. 2009 Jan 1;122(Pt 1):1-4. doi: 10.1242/jcs.035089. Review. No abstract available.


One step at a time: endoplasmic reticulum-associated degradation.

Vembar SS, Brodsky JL.

Nat Rev Mol Cell Biol. 2008 Dec;9(12):944-57. doi: 10.1038/nrm2546. Epub 2008 Nov 12. Review.


Viral and cellular MARCH ubiquitin ligases and cancer.

Wang X, Herr RA, Hansen T.

Semin Cancer Biol. 2008 Dec;18(6):441-50. doi: 10.1016/j.semcancer.2008.09.002. Epub 2008 Oct 2. Review.


Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9.

Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, Ploegh HL.

Nat Immunol. 2008 Dec;9(12):1407-14. doi: 10.1038/ni.1669. Epub 2008 Oct 19.


Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.

Young LJ, Wilson NS, Schnorrer P, Proietto A, ten Broeke T, Matsuki Y, Mount AM, Belz GT, O'Keeffe M, Ohmura-Hoshino M, Ishido S, Stoorvogel W, Heath WR, Shortman K, Villadangos JA.

Nat Immunol. 2008 Nov;9(11):1244-52. doi: 10.1038/ni.1665. Epub 2008 Oct 12.


The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.

Ewald SE, Lee BL, Lau L, Wickliffe KE, Shi GP, Chapman HA, Barton GM.

Nature. 2008 Dec 4;456(7222):658-62. doi: 10.1038/nature07405. Epub 2008 Sep 28.


Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems.

Swift S, Lorens J, Achacoso P, Nolan GP.

Curr Protoc Immunol. 2001 May;Chapter 10:Unit 10.17C. doi: 10.1002/0471142735.im1017cs31.


The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X.

Nathan JA, Sengupta S, Wood SA, Admon A, Markson G, Sanderson C, Lehner PJ.

Traffic. 2008 Jul;9(7):1130-45. doi: 10.1111/j.1600-0854.2008.00747.x. Epub 2008 Apr 11.


Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes.

Thibodeau J, Bourgeois-Daigneault MC, Huppé G, Tremblay J, Aumont A, Houde M, Bartee E, Brunet A, Gauvreau ME, de Gassart A, Gatti E, Baril M, Cloutier M, Bontron S, Früh K, Lamarre D, Steimle V.

Eur J Immunol. 2008 May;38(5):1225-30. doi: 10.1002/eji.200737902.


MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation.

De Gassart A, Camosseto V, Thibodeau J, Ceppi M, Catalan N, Pierre P, Gatti E.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3491-6. doi: 10.1073/pnas.0708874105. Epub 2008 Feb 27.


Biogenesis and function of multivesicular bodies.

Piper RC, Katzmann DJ.

Annu Rev Cell Dev Biol. 2007;23:519-47. Review.


Novel regulation of MHC class II function in B cells.

Matsuki Y, Ohmura-Hoshino M, Goto E, Aoki M, Mito-Yoshida M, Uematsu M, Hasegawa T, Koseki H, Ohara O, Nakayama M, Toyooka K, Matsuoka K, Hotta H, Yamamoto A, Ishido S.

EMBO J. 2007 Feb 7;26(3):846-54. Epub 2007 Jan 25.


A guided tour into subcellular colocalization analysis in light microscopy.

Bolte S, Cordelières FP.

J Microsc. 2006 Dec;224(Pt 3):213-32.


Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination.

van Niel G, Wubbolts R, Ten Broeke T, Buschow SI, Ossendorp FA, Melief CJ, Raposo G, van Balkom BW, Stoorvogel W.

Immunity. 2006 Dec;25(6):885-94.


Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.

Shin JS, Ebersold M, Pypaert M, Delamarre L, Hartley A, Mellman I.

Nature. 2006 Nov 2;444(7115):115-8. Epub 2006 Oct 8.


A novel family of membrane-bound E3 ubiquitin ligases.

Ohmura-Hoshino M, Goto E, Matsuki Y, Aoki M, Mito M, Uematsu M, Hotta H, Ishido S.

J Biochem. 2006 Aug;140(2):147-54. Review.


Inhibition of MHC class II expression and immune responses by c-MIR.

Ohmura-Hoshino M, Matsuki Y, Aoki M, Goto E, Mito M, Uematsu M, Kakiuchi T, Hotta H, Ishido S.

J Immunol. 2006 Jul 1;177(1):341-54. Erratum in: J Immunol. 2006 Sep 1;177(5):3493.


Cysteine cathepsins in the immune response.

Zavasnik-Bergant T, Turk B.

Tissue Antigens. 2006 May;67(5):349-55. Review.


Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.

Mansouri M, Douglas J, Rose PP, Gouveia K, Thomas G, Means RE, Moses AV, Früh K.

Blood. 2006 Sep 15;108(6):1932-40. Epub 2006 Apr 6.

Supplemental Content

Support Center